Lysophosphatidic Acid Decreases the Nuclear Localization and Cellular Abundance of the p53 Tumor Suppressor in A549 Lung Carcinoma Cells

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Cancer Research

• Publication date

  2007-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1541-7786.MCR-06-0338PMID 18025263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• α2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes: A paracrine signal for preadipocyte growth

  2007cited by this paper
• LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho Activation*

  2007cited by this paper
• GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5*

  2006cited by this paper
• A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells

  2005cited by this paper
• Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor

  2005cited by this paper
• Proteasomes degrade proteins in focal subdomains of the human cell nucleus

  2005cited by this paper
• Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex

  2004cited by this paper
• G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival

  2004cited by this paper
• Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.

  2004cited by this paper
• p53: 25 years after its discovery.

  2004cited by this paper
• Lysophosphatidic Acid and Autotaxin Stimulate Cell Motility of Neoplastic and Non-neoplastic Cells through LPA1*

  2004cited by this paper
• Cell surface receptors in lysophospholipid signaling.

  2004cited by this paper
• Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• In Vivo Mitochondrial p53 Translocation Triggers a Rapid First Wave of Cell Death in Response to DNA Damage That Can Precede p53 Target Gene Activation

  2004cited by this paper
• Lipid phosphate phosphatases and related proteins: Signaling functions in development, cell division, and cancer

  2004cited by this paper
• Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.

  2003cited by this paper
• Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family*

  2003cited by this paper
• Nuclear and cytoplasmic degradation of endogenous p53 and HDM2 occurs during down‐regulation of the p53 response after multiple types of DNA damage

  2003cited by this paper
• p53 has a direct apoptogenic role at the mitochondria.

  2003cited by this paper
• LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway.

  2003cited by this paper
• Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway

  2003cited by this paper
• Modulation of phosphoinositide 3‐kinase activation by cholesterol level suggests a novel positive role for lipid rafts in lysophosphatidic acid signalling

  2003cited by this paper
• The emerging role of lysophosphatidic acid in cancer

  2003cited by this paper
• Identification of a Phosphothionate Analogue of Lysophosphatidic Acid (LPA) as a Selective Agonist of the LPA3 Receptor*

  2003cited by this paper
• Nucleocytoplasmic Shuttling of p53 Is Essential for MDM2-Mediated Cytoplasmic Degradation but Not Ubiquitination

  2003cited by this paper
• Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.

  2003cited by this paper
• Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

  2002cited by this paper
• Lysophosphatidic acid protects and rescues intestinal epithelial cells from radiation- and chemotherapy-induced apoptosis.

  2002cited by this paper
• Lysophosphatidic acid is a bioactive mediator in ovarian cancer.

  2002cited by this paper
• Expression of p14ARF overcomes tumor resistance to p53.

  2002cited by this paper
• Nuclear degradation of p53 occurs during down‐regulation of the p53 response after DNA damage

  2002cited by this paper
• Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist

  2002cited by this paper
• The Rat Cytomegalovirus R33-Encoded G Protein-Coupled Receptor Signals in a Constitutive Fashion

  2002cited by this paper
• Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line.

  2001cited by this paper
• A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation

  2001cited by this paper
• Constitutive Signaling by Kaposi's Sarcoma-associated Herpesvirus G-protein-coupled Receptor Desensitizes Calcium Mobilization by Other Receptors*

  2001cited by this paper
• Bimodal effects of platelet-derived growth factor on rat mesangial cell proliferation and death, and the role of lysophosphatidic acid in cell survival.

  2001cited by this paper
• Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.

  2001cited by this paper
• A Single Amino Acid Determines Lysophospholipid Specificity of the S1P1 (EDG1) and LPA1 (EDG2) Phospholipid Growth Factor Receptors*

  2001cited by this paper
• Stress Signals Utilize Multiple Pathways To Stabilize p53

  2000cited by this paper
• Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.

  2000cited by this paper
• Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.

  2000cited by this paper
• Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.

  2000cited by this paper
• Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology.

  2000cited by this paper
• Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.

  2000cited by this paper
• Structural Features of EDG1 Receptor‐Ligand Complexes Revealed by Computational Modeling and Mutagenesis

  2000cited by this paper
• Abnormal serum lysophospholipids in multiple myeloma patients

  1999cited by this paper
• Lysophospholipid receptors: implications for neural signaling.

  1999cited by this paper
• ARF6 requirement for Rac ruffling suggests a role for membrane trafficking in cortical actin rearrangements.

  1999cited by this paper
• Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid*

  1999cited by this paper
• Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid.

  1999cited by this paper
• Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.

  1999cited by this paper
• Clinical prediction rules as guides to treatment.

  1999cited by this paper
• Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.

  1999cited by this paper
• Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.

  1998cited by this paper
• A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid.

  1998cited by this paper
• Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid*

  1998cited by this paper
• Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth.

  1998cited by this paper
• Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

  1998cited by this paper
• Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest*

  1998cited by this paper
• Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.

  1998cited by this paper
• Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.

  1998cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid.

  1997cited by this paper
• The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

  1997cited by this paper
• Peptide and lipid growth factors decrease cis-diamminedichloroplatinum-induced cell death in human ovarian cancer cells.

  1996cited by this paper
• Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy.

  1996cited by this paper
• Apoptosis in erythroid progenitors deprived of erythropoietin occurs during the G1 and S phases of the cell cycle without growth arrest or stabilization of wild-type p53

  1994cited by this paper
• p53-dependent apoptosis suppresses tumor growth and progression in vivo.

  1994cited by this paper
• p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

  1993cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein.

  1992cited by this paper
• Analysis of p53 mutants for transcriptional activity

  1991cited by this paper
• Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division.

  1983cited by this paper
• The binding of actinomycin D and F to bacterial DNA.

  1968cited by this paper
• The mode of action of actinomycin D.

  1960cited by this paper

• The prognostic activity of acylglycerol kinase immunohistochemical expression in colon adenocarcinoma patients

  2023cites this paper
• Overview of G-protein coupled receptors (GPCRs) in adipose tissues and their regulatory roles in the pathophysiology of human diseases

  2023cites this paper
• Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies?

  2021cites this paper
• Overview of the molecular mechanisms contributing to the formation of cancer-associated adipocytes

  2021cites this paper
• Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases

  2020influential citation
• Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment.

  2020cites this paper
• Étude de la régulation transcriptionnelle au locus ENPP2.

  2020cites this paper
• Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.

  2020cites this paper
• Lysophosphatidic acid represses autophagy in prostate carcinoma cells.

  2019cites this paper
• Draft 1 Lysophosphatidic acid represses autophagy in prostate carcinoma cells

  2018cites this paper
• Doxycycline attenuates breast cancer related inflammation by decreasing plasma lysophosphatidate concentrations and inhibiting NF-κB activation

  2017cites this paper
• Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis

  2016cites this paper
• Diverse roles of LPA signaling in the intestinal epithelium.

  2015cites this paper
• Recent advances in targeting the autotaxin-lysophosphatidate-lipid phosphate phosphatase axis in vivo

  2015cites this paper
• Autotaxin – An Enzymatic Augmenter of Malignant Progression Linked to Inflammation

  2015cites this paper
• Lipid phosphate phosphatases and their roles in mammalian physiology and pathology

  2015cites this paper
• Ultra-high-performance liquid chromatography electrospray ionization tandem mass spectrometry for accurate analysis of glycerophospholipids and sphingolipids in drug resistance tumor cells.

  2015cites this paper
• Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer.

  2015cites this paper
• Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox.

  2015cites this paper
• The regulations of miR-30c-3-3p and its antitumor mechanism in ovarian cancer

  2015cites this paper
• Regulation of lysophosphatidate-induced mechanisms of chemo-resistance

  2015cites this paper
• Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions.

  2014cites this paper
• G-protein coupled receptor mediated signaling pathways in chemoresistant melanoma and ovarian cancer

  2014cites this paper
• Autotaxin in the crosshairs: Taking aim at cancer and other inflammatory conditions

  2014cites this paper
• Inhibition of autotaxin delays breast tumor growth and lung metastasis in mice

  2014cites this paper
• Lipid Phosphate Phosphatases and Signaling by Lysophospholipid Receptors

  2013cites this paper
• An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases.

  2013cites this paper
• Understanding the Functions of Lysophosphatidic Acid Receptors in Cancer

  2013cites this paper
• Lysophosphatidic Acid Receptors in Cancer

  2013cites this paper
• Current progress in non-Edg family LPA receptor research.

  2013cites this paper
• Autotaxin and lysophosphatidic acid signalling in lung pathophysiology

  2013cites this paper
• Regulation of Hypoxia-inducible Factor 1α (HIF-1α) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Krüppel-like Factor 5*

  2013cites this paper
• Role of autotaxin and lysophosphatidate in cancer progression and resistance to chemotherapy and radiotherapy

  2012cites this paper
• Signal transduction pathways in hepatocyte cell death : new targets for therapy

  2012cites this paper
• Hepatocyte Apoptosis at the Interplay of Intracellular Organelles andMembrane-Bound Receptors: Targets for Therapy

  2012cites this paper
• GRIM-19 Disrupts E6/E6AP Complex to Rescue p53 and Induce Apoptosis in Cervical Cancers

  2011cites this paper
• Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.

  2011cites this paper
• Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.

  2011cites this paper
• MicroRNA-30c-2* Expressed in Ovarian Cancer Cells Suppresses Growth Factor–Induced Cellular Proliferation and Downregulates the Oncogene BCL9

  2011cites this paper
• LPAR1 (lysophosphatidic acid receptor 1)

  2011cites this paper
• MicroRNA-30 c-2 Expressed in Ovarian Cancer Cells Suppresses Growth Factor – Induced Cellular Proliferation and Downregulates the Oncogene BCL 9

  2011cites this paper
• G protein-coupled receptors: novel targets for drug discovery in cancer

  2010cites this paper
• 24R,25-Dihydroxyvitamin D3, lysophosphatidic acid, and p53: a signaling axis in the inhibition of phosphate-induced chondrocyte apoptosis.

  2010cites this paper
• LPA receptors: subtypes and biological actions.

  2010cites this paper
• G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery.

  2010cites this paper
• Rôle de l’axe Autotaxine (ATX)- Acide Lysophosphatidique (LPA) et récepteur LPA1 dans la dissémination métastatique des cancers du sein

  2010cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2010cites this paper
• 24R,25-dihydroxyvitamin D3 [24R,25(OH)2D3] controls growth plate development by inhibiting apoptosis in the reserve zone and stimulating response to 1alpha,25(OH)2D3 in hypertrophic cells.

  2010cites this paper
• Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three‐dimensional lung cancer xenograft model

  2010cites this paper
• Lipid Mediators and Modulators of Neural Function: Lysophosphatidate and Lysolipids

  2009cites this paper
• Inhibition of autotaxin production or activity blocks lysophosphatidylcholine‐induced migration of human breast cancer and melanoma cells

  2009cites this paper
• Lysophosphatidic acid signaling promotes proliferation, differentiation, and cell survival in rat growth plate chondrocytes.

  2009cites this paper
• Lysophosphatidic acid, vitamin D, and p53: a novel signaling axis in cell death and differentiation

  2009cites this paper
• Nuclear‐Cytosolic Transport of COMMD1 Regulates NF‐κB and HIF‐1 Activity

  2009cites this paper
• 3-Methylindole is mutagenic and a possible pulmonary carcinogen.

  2009cites this paper
• Lipid phosphate phosphatases and signaling The work was supported by the Canadian Institutes of Health Research. Published, JLR Papers in Press, December 9, 2008.

  2009cites this paper
• Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

  2009influential citation
• Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis

  2009cites this paper
• Regulation of p53 expression, phosphorylation and sub-cellular localisation by a G-protein coupled receptor

  2009cites this paper
• Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors.

  2009cites this paper
• Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.

  2008cites this paper
• Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling

  2008cites this paper
• Regulation of Hypoxia-inducible Factor 1 alpha (HIF-1 alpha) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Kruppel-like Factor 5

  year unknowncites this paper